Axonal degeneration as a therapeutic target in the CNS

99Citations
Citations of this article
191Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Degeneration of the axon is an important step in the pathomechanism of traumatic, inflammatory and degenerative neurological diseases. Increasing evidence suggests that axonal degeneration occurs early in the course of these diseases and therefore represents a promising target for future therapeutic strategies. We review the evidence for axonal destruction from pathological findings and animal models with particular emphasis on neurodegenerative and neurotraumatic disorders. We discuss the basic morphological and temporal modalities of axonal degeneration (acute, chronic and focal axonal degeneration and Wallerian degeneration). Based on the mechanistic concepts, we then delineate in detail the major molecular mechanisms that underlie the degenerative cascade, such as calcium influx, axonal transport, protein aggregation and autophagy. We finally concentrate on putative therapeutic targets based on the mechanistic prerequisites. © 2012 The Author(s).

Cite

CITATION STYLE

APA

Lingor, P., Koch, J. C., Tönges, L., & Bähr, M. (2012, July). Axonal degeneration as a therapeutic target in the CNS. Cell and Tissue Research. https://doi.org/10.1007/s00441-012-1362-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free